These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 30788009)

  • 1. The Intersection of Diabetes and Cardiovascular Disease.
    Petak S; Sardhu A
    Methodist Debakey Cardiovasc J; 2018; 14(4):249-250. PubMed ID: 30788009
    [No Abstract]   [Full Text] [Related]  

  • 2. Improved outcomes from diabetes monitoring: the benefits of better adherence, therapy adjustments, patient education, and telemedicine support.
    Klonoff DC
    J Diabetes Sci Technol; 2012 May; 6(3):486-90. PubMed ID: 22768877
    [No Abstract]   [Full Text] [Related]  

  • 3. Back to glycemic control: An alternative look at the results of cardiovascular outcome trials in type 2 diabetes.
    Mannucci E; Monami M; Ceriello A; Rotella CM
    Nutr Metab Cardiovasc Dis; 2017 Apr; 27(4):375-377. PubMed ID: 28242233
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of diabetes mellitus in the elderly.
    Chiniwala N; Jabbour S
    Curr Opin Endocrinol Diabetes Obes; 2011 Apr; 18(2):148-52. PubMed ID: 21522002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for diabetes in patients with cardiovascular disease: HbA1c trumps oral glucose tolerance testing.
    Sattar N; Preiss D
    Lancet Diabetes Endocrinol; 2016 Jul; 4(7):560-2. PubMed ID: 27039357
    [No Abstract]   [Full Text] [Related]  

  • 6. Comprehensive elaboration of glycemic variability in diabetic macrovascular and microvascular complications.
    Sun B; Luo Z; Zhou J
    Cardiovasc Diabetol; 2021 Jan; 20(1):9. PubMed ID: 33413392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Mobile Text Messaging on Glycemic Control in Patients With Coronary Heart Disease and Diabetes Mellitus: A Randomized Clinical Trial.
    Huo X; Krumholz HM; Bai X; Spatz ES; Ding Q; Horak P; Zhao W; Gong Q; Zhang H; Yan X; Sun Y; Liu J; Wu X; Guan W; Wang X; Li J; Li X; Spertus JA; Masoudi FA; Zheng X
    Circ Cardiovasc Qual Outcomes; 2019 Sep; 12(9):e005805. PubMed ID: 31474119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Counterpoint: Intensive glucose control and mortality in ACCORD--still looking for clues.
    Riddle MC
    Diabetes Care; 2010 Dec; 33(12):2722-4. PubMed ID: 21115778
    [No Abstract]   [Full Text] [Related]  

  • 9. Decrease mortality in type II diabetes mellitus: glycemic and renal function control.
    Borghi C; Ventura F
    J Cardiovasc Med (Hagerstown); 2018 Feb; 19 Suppl 1():e13-e15. PubMed ID: 29538138
    [No Abstract]   [Full Text] [Related]  

  • 10. Is glycemic control a quinidine-like intervention?
    Bloomgarden ZT
    J Diabetes; 2014 Sep; 6(5):387-8. PubMed ID: 24842383
    [No Abstract]   [Full Text] [Related]  

  • 11. PDM-ProValue meets cardiovascular outcome trials in diabetes.
    Fritzen K; Schnell O
    Cardiovasc Diabetol; 2019 Jan; 18(1):10. PubMed ID: 30691463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults.
    Selvin E; Steffes MW; Zhu H; Matsushita K; Wagenknecht L; Pankow J; Coresh J; Brancati FL
    N Engl J Med; 2010 Mar; 362(9):800-11. PubMed ID: 20200384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of hemoglobin A1C level with surgical outcomes: Can tight perioperative glucose control reduce infection and cardiac events?
    Shaw P; Saleem T; Gahtan V
    Semin Vasc Surg; 2014 Dec; 27(3-4):156-61. PubMed ID: 26073825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular Risk in Diabetes Mellitus: Complication of the Disease or of Antihyperglycemic Medications.
    Alvarez CA; Lingvay I; Vuylsteke V; Koffarnus RL; McGuire DK
    Clin Pharmacol Ther; 2015 Aug; 98(2):145-61. PubMed ID: 25963811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes: glycated hemoglobin is a marker of diabetes and CVD risk.
    Wareham NJ; Pfister R
    Nat Rev Cardiol; 2010 Jul; 7(7):367-8. PubMed ID: 20577298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes News.
    Regier EE; Gao HX; Close KL
    J Diabetes; 2015 Nov; 7(6):749-53. PubMed ID: 26223410
    [No Abstract]   [Full Text] [Related]  

  • 17. Point: Intensive glycemic control and mortality in ACCORD--a chance finding?
    Lachin JM
    Diabetes Care; 2010 Dec; 33(12):2719-21. PubMed ID: 21115777
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of Purified Anthocyanins in Improving Cardiometabolic Risk Factors in Chinese Men and Women with Prediabetes or Early Untreated Diabetes-A Randomized Controlled Trial.
    Yang L; Ling W; Yang Y; Chen Y; Tian Z; Du Z; Chen J; Xie Y; Liu Z; Yang L
    Nutrients; 2017 Oct; 9(10):. PubMed ID: 28994705
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of pre-diabetes and diabetes on cardiovascular outcomes.
    Anselmino M; Sillano D
    Curr Vasc Pharmacol; 2012 Nov; 10(6):680-3. PubMed ID: 23259552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes: Prevalence, prognosis and management of a potent cardiovascular risk factor.
    Norhammar A; Mellbin L; Cosentino F
    Eur J Prev Cardiol; 2017 Jun; 24(3_suppl):52-60. PubMed ID: 28618910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.